Communication Dans Un Congrès Année : 2020

Understanding heterogeneity in comparative effectiveness studies of natalizumab and fingolimod in multiple sclerosis: effect of analytical methodology

S. Vukusic
Fichier non déposé

Dates et versions

hal-02887182 , version 1 (02-07-2020)

Identifiants

  • HAL Id : hal-02887182 , version 1

Citer

Mathilde Lefort, S. Shannin, Jørgen Vitting Andersen, S. Vukusic, N. J. Koch-Henriksen, et al.. Understanding heterogeneity in comparative effectiveness studies of natalizumab and fingolimod in multiple sclerosis: effect of analytical methodology. 6th Congress of the European Academy of Neurology, European Academy of Neurology, May 2020, On line, United Kingdom. pp.342-342. ⟨hal-02887182⟩
191 Consultations
0 Téléchargements

Partager

  • More